Logo image of ALAVI.PA

ADVINI (ALAVI.PA) Stock Fundamental Analysis

EPA:ALAVI - Euronext Paris - Matif - FR0000053043 - Common Stock - Currency: EUR

13.2  -0.1 (-0.75%)

Fundamental Rating

3

Overall ALAVI gets a fundamental rating of 3 out of 10. We evaluated ALAVI against 25 industry peers in the Beverages industry. Both the profitability and financial health of ALAVI have multiple concerns. While showing a medium growth rate, ALAVI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ALAVI had positive earnings in the past year.
In the past year ALAVI had a positive cash flow from operations.
In multiple years ALAVI reported negative net income over the last 5 years.
In the past 5 years ALAVI always reported a positive cash flow from operatings.
ALAVI.PA Yearly Net Income VS EBIT VS OCF VS FCFALAVI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M 40M

1.2 Ratios

ALAVI has a Return On Assets of 0.07%. This is amonst the worse of the industry: ALAVI underperforms 84.00% of its industry peers.
With a Return On Equity value of 0.34%, ALAVI is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
ALAVI has a worse Return On Invested Capital (3.52%) than 80.00% of its industry peers.
Industry RankSector Rank
ROA 0.07%
ROE 0.34%
ROIC 3.52%
ROA(3y)-0.96%
ROA(5y)-0.58%
ROE(3y)-5.25%
ROE(5y)-3.24%
ROIC(3y)N/A
ROIC(5y)N/A
ALAVI.PA Yearly ROA, ROE, ROICALAVI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

Looking at the Profit Margin, with a value of 0.09%, ALAVI is doing worse than 84.00% of the companies in the same industry.
In the last couple of years the Profit Margin of ALAVI has declined.
Looking at the Operating Margin, with a value of 3.23%, ALAVI is doing worse than 88.00% of the companies in the same industry.
ALAVI's Operating Margin has improved in the last couple of years.
The Gross Margin of ALAVI (36.00%) is worse than 72.00% of its industry peers.
ALAVI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.23%
PM (TTM) 0.09%
GM 36%
OM growth 3Y3.73%
OM growth 5Y6.09%
PM growth 3Y-60.56%
PM growth 5Y-41.13%
GM growth 3Y14.56%
GM growth 5Y8.11%
ALAVI.PA Yearly Profit, Operating, Gross MarginsALAVI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALAVI is destroying value.
Compared to 1 year ago, ALAVI has less shares outstanding
ALAVI has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALAVI has an improved debt to assets ratio.
ALAVI.PA Yearly Shares OutstandingALAVI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALAVI.PA Yearly Total Debt VS Total AssetsALAVI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

ALAVI has an Altman-Z score of 0.70. This is a bad value and indicates that ALAVI is not financially healthy and even has some risk of bankruptcy.
ALAVI has a Altman-Z score of 0.70. This is amonst the worse of the industry: ALAVI underperforms 88.00% of its industry peers.
ALAVI has a debt to FCF ratio of 7.28. This is a slightly negative value and a sign of low solvency as ALAVI would need 7.28 years to pay back of all of its debts.
ALAVI's Debt to FCF ratio of 7.28 is in line compared to the rest of the industry. ALAVI outperforms 52.00% of its industry peers.
ALAVI has a Debt/Equity ratio of 1.41. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of ALAVI (1.41) is worse than 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.41
Debt/FCF 7.28
Altman-Z 0.7
ROIC/WACC0.68
WACC5.2%
ALAVI.PA Yearly LT Debt VS Equity VS FCFALAVI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 0.64 indicates that ALAVI may have some problems paying its short term obligations.
ALAVI has a worse Current ratio (0.64) than 88.00% of its industry peers.
A Quick Ratio of 0.21 indicates that ALAVI may have some problems paying its short term obligations.
With a Quick ratio value of 0.21, ALAVI is not doing good in the industry: 88.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.64
Quick Ratio 0.21
ALAVI.PA Yearly Current Assets VS Current LiabilitesALAVI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

5

3. Growth

3.1 Past

ALAVI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 101.76%, which is quite impressive.
Measured over the past years, ALAVI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -40.47% on average per year.
The Revenue has decreased by -3.23% in the past year.
The Revenue has been growing slightly by 0.81% on average over the past years.
EPS 1Y (TTM)101.76%
EPS 3Y-60.2%
EPS 5Y-40.47%
EPS Q2Q%127.97%
Revenue 1Y (TTM)-3.23%
Revenue growth 3Y-0.32%
Revenue growth 5Y0.81%
Sales Q2Q%-4.45%

3.2 Future

Based on estimates for the next years, ALAVI will show a very strong growth in Earnings Per Share. The EPS will grow by 77.42% on average per year.
The Revenue is expected to grow by 2.72% on average over the next years.
EPS Next Y121.3%
EPS Next 2Y77.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.87%
Revenue Next 2Y2.72%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALAVI.PA Yearly Revenue VS EstimatesALAVI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
ALAVI.PA Yearly EPS VS EstimatesALAVI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 1 1.5

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 188.57, the valuation of ALAVI can be described as expensive.
ALAVI's Price/Earnings ratio is rather expensive when compared to the industry. ALAVI is more expensive than 84.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of ALAVI to the average of the S&P500 Index (26.35), we can say ALAVI is valued expensively.
Based on the Price/Forward Earnings ratio of 71.20, the valuation of ALAVI can be described as expensive.
Based on the Price/Forward Earnings ratio, ALAVI is valued more expensive than 84.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ALAVI to the average of the S&P500 Index (22.19), we can say ALAVI is valued expensively.
Industry RankSector Rank
PE 188.57
Fwd PE 71.2
ALAVI.PA Price Earnings VS Forward Price EarningsALAVI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALAVI is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALAVI indicates a rather cheap valuation: ALAVI is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 1.98
EV/EBITDA 6.37
ALAVI.PA Per share dataALAVI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

ALAVI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ALAVI's earnings are expected to grow with 77.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.55
PEG (5Y)N/A
EPS Next 2Y77.42%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

ALAVI has a Yearly Dividend Yield of 2.08%. Purely for dividend investing, there may be better candidates out there.
ALAVI's Dividend Yield is slightly below the industry average, which is at 2.89.
Compared to an average S&P500 Dividend Yield of 2.40, ALAVI has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.08%

5.2 History

The dividend of ALAVI is nicely growing with an annual growth rate of 13.49%!
Dividend Growth(5Y)13.49%
Div Incr Years0
Div Non Decr Years0
ALAVI.PA Yearly Dividends per shareALAVI.PA Yearly Dividends per shareYearly Dividends per share 2023 0.1 0.2 0.3

5.3 Sustainability

ALAVI's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP0%
EPS Next 2Y77.42%
EPS Next 3YN/A
ALAVI.PA Yearly Income VS Free CF VS DividendALAVI.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

ADVINI

EPA:ALAVI (6/20/2025, 7:00:00 PM)

13.2

-0.1 (-0.75%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)02-13 2025-02-13/amc
Earnings (Next)07-24 2025-07-24
Inst Owners0.3%
Inst Owner ChangeN/A
Ins Owners23.43%
Ins Owner ChangeN/A
Market Cap52.01M
Analysts82
Price Target12.24 (-7.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.08%
Yearly Dividend0.35
Dividend Growth(5Y)13.49%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-31.03%
PT rev (3m)-31.03%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-75.68%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 188.57
Fwd PE 71.2
P/S 0.19
P/FCF 1.98
P/OCF 1.66
P/B 0.73
P/tB 1.69
EV/EBITDA 6.37
EPS(TTM)0.07
EY0.53%
EPS(NY)0.19
Fwd EY1.4%
FCF(TTM)6.67
FCFY50.5%
OCF(TTM)7.97
OCFY60.38%
SpS70.44
BVpS18.06
TBVpS7.83
PEG (NY)1.55
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.07%
ROE 0.34%
ROCE 8.68%
ROIC 3.52%
ROICexc 3.84%
ROICexgc 5.03%
OM 3.23%
PM (TTM) 0.09%
GM 36%
FCFM 9.46%
ROA(3y)-0.96%
ROA(5y)-0.58%
ROE(3y)-5.25%
ROE(5y)-3.24%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y23.09%
ROICexcg growth 5Y20.02%
ROICexc growth 3Y19.05%
ROICexc growth 5Y17.2%
OM growth 3Y3.73%
OM growth 5Y6.09%
PM growth 3Y-60.56%
PM growth 5Y-41.13%
GM growth 3Y14.56%
GM growth 5Y8.11%
F-Score8
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 1.41
Debt/FCF 7.28
Debt/EBITDA 4.44
Cap/Depr 37.64%
Cap/Sales 1.85%
Interest Coverage 0.89
Cash Conversion 138.91%
Profit Quality 10807.4%
Current Ratio 0.64
Quick Ratio 0.21
Altman-Z 0.7
F-Score8
WACC5.2%
ROIC/WACC0.68
Cap/Depr(3y)63.63%
Cap/Depr(5y)65.26%
Cap/Sales(3y)2.99%
Cap/Sales(5y)3.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)101.76%
EPS 3Y-60.2%
EPS 5Y-40.47%
EPS Q2Q%127.97%
EPS Next Y121.3%
EPS Next 2Y77.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.23%
Revenue growth 3Y-0.32%
Revenue growth 5Y0.81%
Sales Q2Q%-4.45%
Revenue Next Year1.87%
Revenue Next 2Y2.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y252.48%
EBIT growth 3Y3.4%
EBIT growth 5Y6.95%
EBIT Next Year315.34%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y383.67%
FCF growth 3Y13.52%
FCF growth 5Y-5.11%
OCF growth 1Y7849.37%
OCF growth 3Y4.32%
OCF growth 5Y-6.75%